Insulin secretion and incretin hormone concentration in women with previous gestational diabetes mellitus

Diabetes and Metabolism Journal

Volumn 35, Issue 1, 2011, Pages 58-64

  Yu, Sung Hoon ^a   Cho, Bongjun ^b   Lee, Yejin ^b   Kim, Eunhye ^b   Choi, Sung Hee ^b,c   Lim, Soo ^b,c   Yi, Ka Hee ^d   Park, Young Joo ^b,c   Park, Kyong Soo ^c   Jang, Hak Chul ^b,c  

^a Hallym University College of Medicine   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

^d Korea Cancer Center Hospital   (South Korea)

Author keywords

Gestational diabetes mellitus; Glucagon; Glucagon like peptide 1; Glucose dependent insulinotropic polypeptide; Insulin secretion

Indexed keywords

EID: 84864809054     PISSN: 22336079     EISSN: 22336087     Source Type: Journal    
DOI: 10.4093/dmj.2011.35.1.58     Document Type: Article

References (19)

1. Metzger BE. Summary and recommendations of the Third International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes 1991;40 Suppl 2:197-201.
2. Buchanan TA, Xiang AH. Gestational diabetes mellitus. J Clin Invest 2005;115:485-91.
3. Hong ES, Lee HJ, Hong YS, Sung EA, Jang YJ. Pospartum assessment of insulin secretion and sensitivity in women with gestational diabetes mellitus (GDM). J Korean Diabetes Assoc 2002;26:319-27.
4. Lim S, Choi SH, Park YJ, Park KS, Lee HK, Jang HC, Cho NH, Metzger BE. Visceral fatness and insulin sensitivity in women with a previous history of gestational diabetes mellitus. Diabetes Care 2007;30:348-53.
5. Ebert R, Creutzfeldt W. Gastrointestinal peptides and insulin secretion. Diabetes Metab Rev 1987;3:1-26.
6. Unger RH, Eisentraut AM. Entero-insular axis. Arch Intern Med 1969;123:261-6.
7. Gerich JE. The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity. Endocr Rev 1998;19:491-503.
8. Nauck M, Stockmann F, Ebert R, Creutzfeldt W. Reduced incretin effect in type 2 (non-insulin-dependent) diabetes. Diabetologia 1986;29:46-52.
9. Vilsboll T, Krarup T, Madsbad S, Holst JJ. Defective amplification of the late phase insulin response to glucose by GIP in obese type II diabetic patients. Diabetologia 2002;45:1111-9.
10. Cypryk K, Vilsboll T, Nadel I, Smyczynska J, Holst JJ, Lewinski A. Normal secretion of the incretin hormones glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 during gestational diabetes mellitus. Gynecol Endocrinol 2007; 23:58-62.
11. Forbes S, Moonan M, Robinson S, Anyaoku V, Patterson M, Murphy KG, Ghatei MA, Bloom SR, Johnston DG. Impaired circulating glucagon-like peptide-1 response to oral glucose in women with previous gestational diabetes. Clin Endocrinol (Oxf) 2005;62:51-5.
12. Jang HC, Yim CH, Han KO, Yoon HK, Han IK, Kim MY, Yang JH, Cho NH. Gestational diabetes mellitus in Korea: prevalence and prediction of glucose intolerance at early postpartum. Di abetes Res Clin Pract 2003;61:117-24.
13. Jang HC, Cho YM, Park KS, Kim SY, Lee HK, Kim MY, Yang JH, Shin SM. Pregnancy outcome in Korean women with gestational diabetes mellitus diagnosed by the carpenter-coustan criteria. J Korean Diabetes Assoc 2004;28:122-30.
14. Katsuki A, Sumida Y, Gabazza EC, Murashima S, Furuta M, Araki-Sasaki R, Hori Y, Yano Y, Adachi Y. Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes. Diabetes Care 2001; 24:362-5.
15. Jensen SL, Nielsen OV, Kuhl C. The enteral insulin-stimulation after pancreas transplantation in the pig. Diabetologia 1976;12: 617-20.
16. Meier JJ, Gallwitz B, Askenas M, Vollmer K, Deacon CF, Holst JJ, Schmidt WE, Nauck MA. Secretion of incretin hormones and the insulinotropic effect of gastric inhibitory polypeptide in women with a history of gestational diabetes. Diabetologia 2005;48:1872-81.
17. Nauck MA, El-Ouaghlidi A, Gabrys B, Hucking K, Holst JJ, Deacon CF, Gallwitz B, Schmidt WE, Meier JJ. Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes. Regul Pept 2004;122:209-17.
18. Nyholm B, Walker M, Gravholt CH, Shearing PA, Sturis J, Alberti KG, Holst JJ, Schmitz O. Twenty-four-hour insulin secretion rates, circulating concentrations of fuel substrates and gut incretin hormones in healthy offspring of type II (non-insulindependent) diabetic parents: evidence of several aberrations. Diabetologia 1999;42:1314-23.
19. Hansotia T, Drucker DJ. GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice. Regul Pept 2005;128:125-34.